-
Grade 3 acute kidney injury caused anti‐glomerular basement membrane nephritis during immune checkpoint inhibitor treatment for melanoma J. Dermatol. (IF 2.9) Pub Date : 2024-09-13 Akemi Fukuda, Dai Ogata, Yoichi Oshima, Eiji Nakano, Kenjiro Namikawa, Motoaki Komatsu, Akira Nakamura, Kohei Sugiura, Naoya Yamazaki
-
A case of solitary encapsulated angiolymphoid hyperplasia with eosinophilia in the hypodermis of possible lymph node origin J. Dermatol. (IF 2.9) Pub Date : 2024-09-13 Keisuke Ueda, Noriko Kato, Hirofumi Niwa, Kazuhiro Kobayashi, Hiroaki Iwata
-
Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials J. Dermatol. (IF 2.9) Pub Date : 2024-09-13 Atsuyuki Igarashi, Gaku Tsuji, Shuichi Fukasawa, Ryusei Murata, Satoshi Yamane
Tapinarof is a nonsteroidal, topical, aryl hydrocarbon receptor agonist. We evaluated the efficacy and safety of tapinarof cream 1% in Japanese patients aged ≥12 years with atopic dermatitis (AD) in two phase 3 trials, ZBB4‐1 and ZBB4‐2. ZBB4‐1 (N = 216) consisted of an 8‐week, double‐blind, vehicle‐controlled treatment period (period 1) and a 16‐week extension treatment period (period 2). Patients
-
A case of IgA vasculitis with Koebner phenomenon of the nose J. Dermatol. (IF 2.9) Pub Date : 2024-09-13 Taiki Nakai, Chikane Maeda, Issei Kido, Kimiko Nakajima, Yuki Osakabe, Tatsuki Matsumoto, Yuki Ogasawara, Yusuke Oki, Kozo Nakai
-
Psoriasis treatment and biologic switching: The association with clinical characteristics and laboratory biomarkers over a 13‐year retrospective study J. Dermatol. (IF 2.9) Pub Date : 2024-09-13 Asumi Koyama, Lixin Li, Toyoki Yamamoto, Haruka Taira, Eiki Sugimoto, Yukiko Ito, Yuka Mizuno, Kentaro Awaji, Shoko Tateishi, Hiroko Kanda, Shinichi Sato, Sayaka Shibata
The advent of biologics has greatly improved patient outcomes, yet some patients are compelled to switch therapies. Predicting these therapeutic failures is important; however, the factors associated with switching biologics have not been fully explored. This study examined patterns and determinants of biologics switching in psoriasis treatment retrospectively over 13 years. We focused on the association
-
Case of tinea corporis caused by a terbinafine‐sensitive Trichophyton indotineae strain in a Vietnamese worker in Japan J. Dermatol. (IF 2.9) Pub Date : 2024-09-13 Takashi Mochizuki, Kazushi Anzawa, Andrea Marie Bernales‐Mendoza, Akira Shimizu
A 42‐year‐old Vietnamese egg factory worker in Ishikawa prefecture, Japan, presented with itchy concentric erythema on the trunk and left calf. The lesions tested positive by direct potassium hydroxide examination, and two fungal strains were isolated. The isolates produced conidia abundantly and were morphologically indistinguishable from Trichophyton mentagrophytes/interdigitale, but were identified
-
Nevus comedonicus with lesional growth of terminal hair: An unusual case J. Dermatol. (IF 2.9) Pub Date : 2024-09-13 Hazem A. Juratli, Matiar Madanchi, Riccardo Curatolo, Dario Didona, Rudolph Happle
-
Comparison of efficacy between anti‐PD‐1 antibody monotherapy and nivolumab plus ipilimumab therapy as first‐line immunotherapy for advanced mucosal melanoma in Japanese patients: A single‐center, retrospective cohort study J. Dermatol. (IF 2.9) Pub Date : 2024-09-13 Ken Horisaki, Shusuke Yoshikawa, Wataru Omata, Arata Tsutsumida, Yoshio Kiyohara
Mucosal malignant melanoma (MMM) is a rare subtype of malignant melanoma with a more aggressive biological behavior than cutaneous melanoma (CM). Owing to its rarity, it is necessary to accumulate information on treatments, especially in Asians, in whom MMM occurs more frequently than in Caucasians. In this study, we investigated the efficacy and adverse events (AEs) of nivolumab plus ipilimumab therapy
-
A case of familial progressive hyperpigmentation with or without hypopigmentation presenting with hypopigmented striae along the lines of Blaschko J. Dermatol. (IF 2.9) Pub Date : 2024-09-13 Tokimasa Hida, Masashi Idogawa, Aki Ishikawa, Masae Okura, Satoru Sasaki, Takashi Tokino, Hisashi Uhara
Familial progressive hyperpigmentation with or without hypopigmentation (FPHH) is an autosomal dominant disorder characterized by widespread skin hyperpigmentation, café‐au‐lait spots, and hypopigmented circular macules, resulting from KITLG variants. KITLG, expressed by keratinocytes, binds to KIT on melanocytes, stimulating melanogenesis. Disturbances in the KITLG‐KIT interaction result in diffuse
-
Analysis of disease burden in patients with hereditary angioedema from Japan by patient‐reported outcomes J. Dermatol. (IF 2.9) Pub Date : 2024-09-11 Michihiro Hide, Miwa Kishimoto, Ippei Kotera, Akinori Oh, Yoichi Inoue, Beverley Anne Yamamoto, Shinichi Noto
Hereditary angioedema (HAE) symptoms can vary greatly. Disease burden evaluation is essential for providing adequate treatments for patients. Patient‐reported outcome measures (PROMs), including the 12‐Item Short Form Health Survey (SF‐12), the Angioedema Quality of Life (AE‐QoL), the Hospital Anxiety and Depression Scale (HADS), and the Work Productivity and Activity Impairment: Specific Health Problem
-
Clinical and laboratory features between anti‐TIF1γ dermatomyositis with and without malignancy: 37 case series and a review J. Dermatol. (IF 2.9) Pub Date : 2024-09-11 Ke‐yun Tang, Han‐lin Zhang, Xin‐yi Zhang, Hong‐zhong Jin
We aimed to analyze the clinical profile and malignancy indicators in dermatomyositis (DM) with anti‐transcriptional intermediary factor 1 antibody (anti‐TIF1γ‐Ab). A comparison was made between clinical information of anti‐TIF1γ DM patients with and without malignancy. Additionally, a review of the literature on anti‐TIF1γ DM and malignancy was conducted by searching PubMed and EMBASE databases. In
-
Coexistence of Basan syndrome and cutaneous basal cell carcinoma: Genetic and clinical perspectives J. Dermatol. (IF 2.9) Pub Date : 2024-09-10 Zhijie Luo, Yansi Lyu, Wenwu Dong, Zhongxi Mei, Huijun Wang, Fang Yang
-
HPV 51‐associated inguinal SCC on an atopic dermatitis patient treated with cyclosporine J. Dermatol. (IF 2.9) Pub Date : 2024-09-10 Tomotaka Sato, Manabu Nakazono, Keita Ohyachi, Aya Okaniwa, Hisashi Kobayashi, Kazuto Yamazaki
-
Exploratory study on short‐term administration of oral fosravuconazole for tinea pedis J. Dermatol. (IF 2.9) Pub Date : 2024-09-10 Yuichiro Tsunemi, Wataru Naka
We investigated the clinical efficacy of short‐term, oral fosravuconazole (F‐RVCZ) therapy for tinea pedis, commonly known as athlete's foot. F‐RVCZ (equivalent to 100 mg ravuconazole) was administered orally once daily for 1 week for interdigital and vesicular tinea pedis and for 4 weeks for hyperkeratotic tinea pedis. Efficacy was evaluated based on mycological efficacy and clinical symptoms at Weeks
-
Perspectives of Japanese patients on psoriatic disease burden: Results from “Psoriasis and Beyond,” the Global Psoriatic Disease Survey J. Dermatol. (IF 2.9) Pub Date : 2024-09-10 Masanori Okuse, Masayuki Soekawa, Asako Itakura, Taisuke Kawamura, Sicily Mburu, Susan Frade, Yukari Okubo
Psoriatic disease (PsD) is a chronic disease affecting skin (psoriasis) and joints (psoriatic arthritis, PsA) that has a significant impact on patients' quality of life (QOL). We report findings from the Japanese subgroup of patients included in Psoriasis and Beyond: The Global Psoriatic Disease Survey, a cross‐sectional, quantitative online survey of patients with self‐reported, healthcare professional
-
Correction to “Erythema nodosum in northern Finland between 1996 and 2019: A register‐based study” J. Dermatol. (IF 2.9) Pub Date : 2024-09-06
-
Predictors of clinical features in early‐onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort J. Dermatol. (IF 2.9) Pub Date : 2024-09-05 Saori Uesugi‐Uchida, Manabu Fujimoto, Yoshihide Asano, Hirahito Endo, Daisuke Goto, Masatoshi Jinnin, Yasushi Kawaguchi, Sumiaki Tanaka, Takahiro Tokunaga, Katsunari Makino, Takashi Matsushita, Sei‐Ichiro Motegi, Ayumi Yoshizaki, Shinichi Sato, Minoru Hasegawa
As the clinical course of systemic sclerosis (SSc) varies widely, prognostic indicators have been sought to predict the outcomes of individual patients. Racial differences in SSc render it necessary to validate prognostic indicators in different patient cohorts. In this study, we aimed to assess clinical and laboratory parameters in Japanese patients with early‐stage SSc with diffuse cutaneous involvement
-
Comparative analysis of one‐step and two‐step full thickness skin grafting and secondary intention healing for skin defects after surgical management of plantar malignant melanoma J. Dermatol. (IF 2.9) Pub Date : 2024-09-04 Hiroshi Kato, Shinji Kano, Maki Yoshimitsu, Yua Nakagawa, Yukiko Yasui, Motoki Nakamura, Akimichi Morita
Plantar malignant melanoma is largely managed surgically, particularly in its early stages. However, the plantar region has a lower survival rate of skin grafts than other regions. Furthermore, complete wound healing occurs over a long period of time, postoperatively. Thus, in this study, we retrospectively analyzed the use of skin grafts to reconstruct skin defects, as postoperative complications
-
A case of eczematous paradoxical reactions on the extremities during tildrakizumab treatment for plaque psoriasis J. Dermatol. (IF 2.9) Pub Date : 2024-09-04 Nao Kawano, Chisa Nakashima, Atsushi Otsuka
-
Association of hidradenitis suppurativa (HS) with waist circumference: A bidirectional two‐sample Mendelian randomization study of HS with metabolic syndrome J. Dermatol. (IF 2.9) Pub Date : 2024-09-04 Huaiyu Wang, Baofeng Wu, Min Luo, Yue Han, Jinhua Chen, Jingjing Liu, Lihang Lin, Xuemin Xiao
Observational studies have suggested an associations between hidradenitis suppurativa (HS) and metabolic syndrome (MetS) and its components. However, it remains unclear whether the relationship is causal or not. Our study aimed to investigate the causal association of HS with MetS and its components. We performed a bidirectional, two‐sample Mendelian randomization study using summary‐level data from
-
Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI study J. Dermatol. (IF 2.9) Pub Date : 2024-09-04 Akimichi Morita, Yukari Okubo, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, A. E. J. Gibson, Frauke Becker, Nataliya Bogoeva, Mamitaro Ohtsuki
Our objective was to establish consensus on (1) which patients with plaque psoriasis and limited skin involvement (body surface area [BSA] <10%) are suitable for systemic treatment, and (2) a definition of ‘topical therapy failure’. A steering committee refined 13 statements drawn from literature related to the study objectives. An independent panel of 45 clinical experts from Japan indicated their
-
Current clinical practice of prurigo nodularis in Japan: A cross‐sectional web‐survey among dermatologists J. Dermatol. (IF 2.9) Pub Date : 2024-09-03 Hiroyuki Murota, Mai Matsumoto, Kazuhiko Arima, Takuo Yoshida, Hiroyuki Fujita
Prurigo nodularis (PN) is a chronic inflammatory skin disease associated with intense pruritic nodules. The unclear patho‐etiological mechanisms of PN cause difficulty in disease management; and there is a paucity of information on the current diagnosis and treatment options for PN in Japan. To describe the current management from a dermatologists' perspective we conducted a web‐based survey (UMIN
-
-
-
Relationship between acne vulgaris and attention deficit hyperactivity disorder in adolescent: A cross‐sectional study J. Dermatol. (IF 2.9) Pub Date : 2024-08-30 Huriye Aybüke Koç, Bedia Sultan Önal
High androgen hormone exposure in intrauterine life is held to be responsible for the etiopathogenesis of both acne vulgaris (AV) and attention‐deficit hyperactivity disorder (ADHD). In this study, we aimed to investigate the prevalence of ADHD in AV patients. Patients between the ages of 12 and 17, diagnosed with AV and a control group were included in the study. The Conners‐Wells Adolescent Self‐Report
-
Author reply to “regarding “retrospective study of the clinical significance of the neutrophil‐to‐lymphocyte ratio in 79 patients with palmoplantar pustulosis”” J. Dermatol. (IF 2.9) Pub Date : 2024-08-29 Tomoya Watanabe, Yukie Yamaguchi
-
HLA‐C*06:02 in Danish patients with psoriasis and response to biological treatment J. Dermatol. (IF 2.9) Pub Date : 2024-08-27 Mie Siewertsen Bergmann, Nikolai Loft, Christopher Willy Schwarz, Diljit Kaur‐Knudsen, Claus Zachariae, Lone Skov
Whether clinical and genetic markers can be used to differentiate patients with varying responses to different psoriasis therapies needs to be elucidated. Here, we assess whether human leukocyte antigen C (HLA‐C)*06:02 is associated with response to biologics. Response to treatment was defined as a Psoriasis Area and Severity Index score of ≤2 (PASI≤ 2) after 3 months. In total, 648 patients with psoriasis
-
Regarding “retrospective study of the clinical significance of the neutrophil‐to‐lymphocyte ratio in 79 patients with palmoplantar pustulosis” J. Dermatol. (IF 2.9) Pub Date : 2024-08-21 Zhuoqun Wei, Lüe Hong, Xingang Wu
-
Diffuse planar xanthomatosis in the setting of monoclonal gammopathy of undetermined significance J. Dermatol. (IF 2.9) Pub Date : 2024-08-21 Marisa Lenga, Jennifer Nam Choi
-
A case of siliconoma in the penis in which microanalysis was useful for diagnosis. J. Dermatol. (IF 2.9) Pub Date : 2024-08-20 Hirotaka Midorikawa,Yukiko Kiniwa,Ryuhei Okuyama
-
Successful treatment with spesolimab for generalized pustular psoriasis in an elderly patient with TRPM4 mutation J. Dermatol. (IF 2.9) Pub Date : 2024-08-19 Daniel Meng‐Yen Hsieh, Panpan Shang, Yusi Gao, Jiahui Zhao
-
Perianal cutaneous malakoplakia in a patient with anti‐MDA5 dermatomyositis J. Dermatol. (IF 2.9) Pub Date : 2024-08-19 Hinako Saito, Jun Omatsu, Yuko Takasaki, Yurika Osuji, Hirohito Kotani, Moe Sakakibara, Shinji Sunaga, Asako Yoshizaki, Takuya Miyagawa, Shinichi Sato
-
Possible effectiveness of switching biologics from adalimumab to certolizumab pegol in pyoderma gangrenosum J. Dermatol. (IF 2.9) Pub Date : 2024-08-19 Minoru Kimura, Akihiko Uchiyama, Yukie Endo, Masahito Yasuda, Sei‐ichiro Motegi
-
Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome J. Dermatol. (IF 2.9) Pub Date : 2024-08-19 Marina Hamada, Tokimasa Hida, Masashi Idogawa, Shoichiro Tange, Takafumi Kamiya, Masae Okura, Toshiharu Yamashita, Takashi Tokino, Hisashi Uhara
Multiple hereditary infundibulocystic basal cell carcinoma syndrome (MHIBCC), an autosomal dominant disorder caused by variants in SUFU, is characterized by numerous infundibulocystic basal cell carcinomas (IBCCs). In this report, we present a possible case of mosaic MHIBCC. A 57‐year‐old woman underwent the removal of four papules on her face, which were diagnosed as IBCCs. Exome sequencing revealed
-
Changes in skin bacterial flora during the healing process of ulcer caused by self‐destruction of lymph nodes due to tuberculous lymphadenitis J. Dermatol. (IF 2.9) Pub Date : 2024-08-19 Makoto Kondo, Daiki Goto, Koji Habe, Naohisa Yamazoe, Keiichi Yamanaka
An 86‐year‐old woman with residual left hemiplegia from a prior stroke, residing in a nursing facility, presented with swelling of the right side of her neck. Tuberculous lymphadenitis was diagnosed through polymerase chain reaction analysis and sputum culture, leading to treatment with isoniazid, rifampicin, and ethambutol. After 2 months, an abscess and ulcer formed; analysis of the bacterial flora
-
Anti‐p200 pemphigoid recurred with erythema multiforme‐like lesions J. Dermatol. (IF 2.9) Pub Date : 2024-08-19 Gaojie Li, Qin Tan, Mei Yang, Ming Yao, Bo Wu, Ran Huang, Yuxi Zhou, Wei Li, Yonghong Lu, Bin Yin
-
Tapinarof cream for the treatment of plaque psoriasis: Efficacy and safety results from 2 Japanese phase 3 trials J. Dermatol. (IF 2.9) Pub Date : 2024-08-16 Atsuyuki Igarashi, Gaku Tsuji, Shuichi Fukasawa, Ryusei Murata, Satoshi Yamane
Tapinarof is a non‐steroidal, topical, aryl hydrocarbon receptor agonist. We evaluated the efficacy and safety of tapinarof cream (1%) in Japanese patients aged ≥18 years with plaque psoriasis in two phase 3 trials, ZBA4‐1 and ZBA4‐2. ZBA4‐1 (N = 158) consisted of a 12‐week, double‐blind, vehicle‐controlled treatment period (period 1) and a 12‐week extension treatment period (period 2). Patients were
-
A case of metastasis of giant basal cell carcinoma in oculocutaneous albinism J. Dermatol. (IF 2.9) Pub Date : 2024-08-12 Maho Matsuo, Hirofumi Niwa, Hiroaki Iwata
-
Coincidence of acral peeling skin syndrome and Nagashima‐type palmoplantar keratosis in a Japanese pedigree with acral skin peeling J. Dermatol. (IF 2.9) Pub Date : 2024-08-12 Toshihide Higashino, Mayu Konomi, Akiharu Kubo, Hiroshi Horinosono, Yoshinori Miura
Acral peeling skin syndrome (APSS; MIM 609796) is a rare genodermatosis characterized by painless focal cutaneous exfoliation of the dorsal hands and feet, typically displaying autosomal recessive inheritance. While cases associated with a founder mutation in TGM5 are relatively common in European Caucasian populations, no APSS cases have been reported from Japan or other East Asian countries. In contrast
-
Effectiveness of bimekizumab for genital, nail, and scalp lesions with psoriasis: A 24‐week real‐world study J. Dermatol. (IF 2.9) Pub Date : 2024-08-12 Teppei Hagino, Marina Onda, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda
Psoriasis is a complex, chronic inflammatory skin disease that significantly impacts patients' quality of life (QOL), especially in cases of genital, nail, and scalp psoriasis. Bimekizumab is an inhibitor of interleukin (IL)‐17A and IL‐17F and used for the treatment of psoriasis. The aim of this retrospective study was to evaluate the effectiveness of bimekizumab through in treating genital, nail,
-
Rosacea in East Asian populations: Clinical manifestations and pathophysiological perspectives for accurate diagnosis J. Dermatol. (IF 2.9) Pub Date : 2024-08-10 Yoshimasa Nobeyama
Rosacea is a chronic inflammatory disorder primarily affecting the facial skin, prominently involving the cheeks, nose, chin, forehead, and periorbital area. Cutaneous manifestations encompass persistent facial erythema, phymas, papules, pustules, telangiectasia, and flushing. The pathogenesis of rosacea is associated with various exacerbating or triggering factors, including microbial infestation
-
Primary localized cutaneous nodular amyloidosis of the scalp arising from folliculitis decalvans J. Dermatol. (IF 2.9) Pub Date : 2024-08-10 Honoka Takahashi, Hiroki Morimoto, Yuki Sugimura, Tetsuya Honda
-
A clinical case of anaphylaxis after eating oatmeal contaminated with booklice (Liposcelis bostrychophila) J. Dermatol. (IF 2.9) Pub Date : 2024-08-10 Chinatsu Matsumoto, Yuji Kawakami, Osamu Ishibashi, Ikumi Sagara, Masaya Sakaguchi, Yuya Harada, Misaki Takahashi, Shiro Niiyama, Takashi Inui, Hidetsugu Fukuda
A 52‐year‐old man presented to our department with generalized erythema, watery stools, and vomiting 30 min after ingesting coconut, oatmeal, and vegetable juice. On arrival, his blood pressure was 120/79 mm Hg, heart rate was 126 beats per min, blood oxygen saturation was 96%, and lip cyanosis was observed. The patient experienced diffuse redness throughout the body and was diagnosed as having severe
-
A case of Pott's puffy tumor arising during treatment with lenvatinib and denosumab J. Dermatol. (IF 2.9) Pub Date : 2024-08-10 Yoshinori Muto, Takashi Okamoto, Youichi Ogawa, Hiroshi Mitsui, Shinji Shimada, Tatsuyoshi Kawamura
-
Impact of new antifungal medications on onychomycosis prescriptions and costs in Japan: A nationwide claims database study J. Dermatol. (IF 2.9) Pub Date : 2024-08-08 Hideaki Miyachi, Daisuke Sato, Kentaro Sakamaki, Yaei Togawa, Kensuke Yoshimura
Onychomycosis, a fungal nail infection, is a common dermatological condition in Japan, with a prevalence of approximately 5%–10%. Despite the introduction of new antifungal medications and updated treatment guidelines published in 2019, data on real‐world prescription trends and the associated medical costs are limited. This study aimed to investigate the prescription patterns and medical costs of
-
Simultaneous distinct cutaneous fungal infections with chromoblastomycosis due to Exophiala xenobiotica and hyalohyphomycosis due to Scedosporium apiospermum in a patient with severe cellular immunodeficiency J. Dermatol. (IF 2.9) Pub Date : 2024-08-05 Fumika Minakawa, Takenobu Yamamoto, Yumi Aoyama
Deep‐seated dermatomycosis is a rare disease that is often caused by trauma and/or systemic immunodeficiency. We describe a case of chromoblastomycosis complicated by hyalohyphomycosis that occurred simultaneously at different sites. A 92‐year‐old Japanese man who had been taking oral prednisolone for an IgG4‐related respiratory disease visited our clinic. He developed brownish plaques with grayish‐white
-
Correction to ‘Case of systemic sclerosis overlapping with neuromyelitis optica’ J. Dermatol. (IF 2.9) Pub Date : 2024-08-02
-
Annular elastolytic giant cell granuloma aggravated by oral 5‐aminolevulinic acid and sunlight exposure J. Dermatol. (IF 2.9) Pub Date : 2024-08-01 Mikoto Inoue, Hisayoshi Imanishi, Junka Gon, Jun Nagao, Hirofumi Sato, Takashi Fukumoto, Daisuke Tsuruta
-
Emergence of verrucous psoriasis post‐secukinumab therapy J. Dermatol. (IF 2.9) Pub Date : 2024-08-01 Zhixuan Guo, Menger Guo, Guangji Gui, Yuhua Liu, Xiangyun Li
-
-
Ozenoxacin suppresses sebum production by inhibiting mTORC1 activation in differentiated hamster sebocytes J. Dermatol. (IF 2.9) Pub Date : 2024-08-01 Takamichi Kitano, Toshikazu Koiwai, Koki Fujikawa, Sachi Mori, Tatsumi Matsumoto, Takashi Sato
Acne vulgaris is a complex condition involving factors that affect the pilosebaceous unit. A primary manifestation of acne pathology is the development of comedones, often linked to the overproduction of sebum resulting from 5α‐dihydrotestosterone (5α‐DHT) and insulin activity. Ozenoxacin is a topical quinolone that exhibits potent antibacterial activity against Cutibacterium acnes (C. acnes). It is
-
-
A case of bullous pemphigoid associated with psoriasis showing no tissue‐bound immunoglobulin G on the inflamed skin J. Dermatol. (IF 2.9) Pub Date : 2024-07-29 Dongjun Im, Keisuke Ueda, Hirofumi Niwa, Kayoko Tanaka, Hiroaki Iwata
-
Pyrin‐associated autoinflammation with neutrophilic dermatosis: A case report J. Dermatol. (IF 2.9) Pub Date : 2024-07-29 Rocío C. Bueno‐Molina, Juan‐Carlos Hernández‐Rodríguez, Teresa Zulueta‐Dorado, Jose‐Juan Pereyra‐Rodriguez
Pyrin‐associated autoinflammation with neutrophilic dermatosis (PAAND) is a rare, monogenic, autoinflammatory disorder caused by mutations in exon 2 of the MEFV gene. Characterized by neutrophilic dermatosis, recurrent fever, and arthralgia, this syndrome presents a diagnostic challenge due to its low prevalence and varied clinical manifestations. Here, we present the case of a 49‐year‐old Spanish
-
Variants in the L12 linker domain of KRT10 are causal to atypical epidermolytic ichthyosis J. Dermatol. (IF 2.9) Pub Date : 2024-07-29 J. J. A. J. van der Velden, M. W. van Gisbergen, M. A. F. Kamps, R. Janssen, G. F. H. Diercks, P. M. Steijlen, M. van Geel, M. C. Bolling
Epidermolytic ichthyosis (EI) is a type of congenital ichthyosis, characterized by erythema and blistering at birth followed by hyperkeratosis. EI is caused by pathogenic variants in the genes KRT1 and KRT10, encoding the proteins keratin 1 (KRT1) and keratin 10 (KRT10), respectively, and is primarily transmitted by autosomal‐dominant inheritance, although recessive inheritance caused by nonsense variants
-
Immunohistopathological analyses of a case of pemphigus vegetans with antibodies against desmoglein 1 and desmocollins 1–3 J. Dermatol. (IF 2.9) Pub Date : 2024-07-29 Anri Kimura, Teruhiko Makino, Shohei Kitayama, Megumi Mizawa, Norito Ishii, Takashi Hashimoto, Tadamichi Shimizu
Pemphigus vegetans is a rare type of pemphigus characterized by vegetative lesions primarily localized to the intertriginous area. Despite its unique clinical presentation, the underlying pathomechanism remains unclear owing to the rarity of the disease. We report a case of pemphigus vegetans with antibodies against desmoglein 1 and desmocollins 1–3. Furthermore, immunohistochemical analyses were performed
-
Mosaic KRAS mutations cause an atypical variant of phacomatosis spilosebacea J. Dermatol. (IF 2.9) Pub Date : 2024-07-27 Daniele Torchia
-
A case of chronic ulcerative herpes simplex virus infection in a patient with bullous pemphigoid J. Dermatol. (IF 2.9) Pub Date : 2024-07-26 Nana Adachi, Kensuke Fukuchi, Tomoko Sugiyama, Keiko Sakamoto, Tetsuya Honda
-
Genomic profiles of Merkel cell carcinoma in Japan J. Dermatol. (IF 2.9) Pub Date : 2024-07-26 Junji Kato, Tokimasa Hida, Masashi Idogawa, Takashi Tokino, Hisashi Uhara
-
Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome associated with acute‐on‐chronic pancreatitis: A case report J. Dermatol. (IF 2.9) Pub Date : 2024-07-25 Toshiki Okazaki, Takehiro Takahashi, Yoshihide Asano